Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Galderma Laboratories LP et al v. Par Pharmaceutical Inc
Case Number:
3:12-cv-02563
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 17, 2013
Galderma Settles Pimple Drug Patent Suit With Par
Swiss skincare company Galderma SA and Par Pharmaceutical Inc. told a Texas federal court Friday they had reached a settlement over allegations that the generics maker sought to market a knockoff of Galderma's Epiduo acne treatment.
-
July 30, 2012
Galderma Says Watson Generic Infringes Acne Ointment Patents
Watson Pharmaceuticals Inc. on Friday was sued in Texas federal court by Swiss skincare treatment company Galderma SA for allegedly seeking to market a knockoff of acne treatment Epiduo that infringes several Galderma patents.